Eli Lilly is buying a biotech startup for nearly $3 billion to expand into autoimmune diseases
- Eli Lilly: 4 events in the last 90 days
- Previous: 2 days earlier · Eli Lilly's diabetes drug wins FDA approval to lower heart attack and stroke risk
What happened
The deal adds a pipeline targeting the antibodies behind Graves' disease, thyroid eye disease, food allergy, and other conditions
Summary assembled by rule from the sources below